Neurotransmitters & CNS Disease, Basal Ganglia Disease
Lancet 2:1141-1147, Marsden,C.D., 1982
Metoclopramide-Induced Parkinsonism
Arch Neurol 39:494-496, Indo,T.,et al, 1982
A Danger In Making The Diagnosis Of Parkinson's Disease
Lancet 1:1212-1213, Murdoch,P.S.,et al, 1982
Reversible Drug-Induced Parkinsonism
Arch Neurol 39:644-646, Rajput,A.H.,et al, 1982
A Pure Parkinsonian Syndrome Following Acute Carbon Monoxide Intoxication
Arch Neurol 39:302-304, Klawans,H.L.,et al, 1982
Bromocriptine:Low-dose Therapy in Parkinson Disease
Neurol 32:577-583, Teychenne,P.F.,et al, 1982
Treatment of the"On-Off"Phenomenon Parkinsonism with Lithium Carbonate
Ann Neurol 12:375-379, Coffey,C.E.,et al, 1982
Deprenyl In Parkinson's Disease
Lancet 2:695-696, , 1982
Alcohol & Parkinson Disease
Ann Neurol 12:254-256, Lang,A.E.,et al, 1982
Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982
Pergolide in Late-Stage Parkinson Disease
Ann Neurol 12:243-247, Lang,A.E.,et al, 1982
Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982
1918 Influenza, Encephalitis Lethargica, Parkinsonism
Lancet 2:860-864, Ravenholt,R.T.,et al, 1982
Blink Rates in Parkinsonism
Ann Neurol 12:580-583, Karson,C.N.,et al, 1982
Alternate Day Levodopa Therapy in Parkinsonism
Neurol 32:324-326, Koller,W.C., 1982
Lisuride Combined with Levodopa in Advanced Parkinson Disease
Neurol 31:1466-1469, Lieberman,A.N.,et al, 1981
Post-encephalitic Parkinsonism:Current Experience
JNNP 44:670-676, Rail,D.,et al, 1981
Speech Disorders of Parkinsonism:A Review
JNNP 44:751-758, Critchley,E.M.R., 1981
Sinemet & the Treatment of Parkinsonism
Ann Int Med 94:364-370, Boshes,B., 1981
Evidence to Support Early Levodopa Therapy in Parkinson Disease
Neurol 31:125-131, Markham,C.H.,et al, 1981
Hemiparkinsonism as a Late Complication of Hemiatrophy:A New Syndrome
Neurol 31:625-627, Klawans,H.L., 1981
Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981
Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981
Twin Study of Parkinson Disease
Neurol 31:77-80, Duvoisin,R.C.,et al, 1981
Thyroid Function Parkinson Disease
Neurol 31:93-95, Berger,J.R.,et al, 1981
Deprenyl in Parkinson Disease
Neurol 31:19-23, Eisler,T.,et al, 1981
Parkinsonism Provoked by Alcoholism
Ann Neurol 9:84-86, Carlen,P.L.,et al, 1981
Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981
Depression, Intellectual Impairment & Parkinson Disease
Neurol 31:645-650, Mayeux,R.,et al, 1981
Progressive Supranuclear Palsy:Functional Analysis of the Response to Methysergide & Antiparkinsonian Agents
Neurol 31:1507-1518, Rafal,R.D.,et al, 1981
Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981
Parkinsonism & Tardive Dyskinesia Associated With Long-Term Metoclopramide Therapy
NEJM 305:1417, Grimes,J.D., 1981
Weekly Drug Holiday in Parkinson Disease
Neurol 31:1460-1462, Goetz,C.G.,et al, 1981
Progressive Supranuclear Palsy, Computed Tomography, & Response to Antiparkinsonian Drugs
Neurol 31:442-445, Haldeman,S.,et al, 1981
Amyotrophic Lateral Sclerosis & its Association with Dementia, Parkinsonism & Other Neurological Disorders:A Review
Brain 104:217-247, Hudson,A.J., 1981
Dysphagia in Parkinson's Disease
Am J Gastroenterol 74:157-160, Lieberman,A.N.,et al, 1980
Neurological Disease In Ex-Far-East Prisoners Of War
Lancet 2:135-137, Gibberd,F.B.,et al, 1980
Amyloid Neuropathy & Tremor in Waldenstrom's Macroglobulinemia
Arch Neurol 37:240-242, Bajada,S.,et al, 1980
Is L-DOPA Drug Holiday Useful
Neurol 30:785-788, Direnfield,L.K.,et al, 1980
Drug Holiday & Management of Parkinson Disease
Neurol 30:1257-1261, Weiner,W.J.,et al, 1980
Parkinson Disease, Dementia, & Alzheimer Disease:Clinicopathological Correlations
Ann Neurol 7:329-335, Boller,F.,et al, 1980
Dystonic Foot Response of Parkinsonism
Arch Neurol 37:132-136, Nausieda,P.A.,et al, 1980
Levels of y-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol 37:352-355, Manyam,N.V.B.,et al, 1980
Diagnosis & Treatment, Physiologic & Pathologic Tremors
Ann Int Med 93:460-465, Jankovic,J.,et al, 1980
Intracranial Calcification in Hyperparathyroidism Associated with Gait Apraxia & Parkinsonism
Neurol 30:1005-1007, Margolin,D.,et al, 1980
Cigarette Smoking & Parkinson Disease:1. A Comparison of Cases with Matched Neighbors
Neurol 30:839-843, Baumann,R.J.,et al, 1980
The Occupational Therapist & the Patient with Parkinson's Disease
BMJ 280:1354-1355, Beattie,A.,et al, 1980
Nervous System Toxicity of Chemo Agents
Young, DF, in Vinken PJ, Bruyn GW, Handbook of Clin Neurol, North-Holland Publ Co, Amster, Vol 39, 1, 80, p 104, 1980
Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980
Drug Holidays for Patients with Parkinsonism
JAMA 242:17-21, Clark,W.A., 1979